"What I can say to the people that are starting to study aging now is that I think we are on the verge of a revolution, that the science of aging is maturing and becoming a medical science, and a discipline that every doctor will have to be competent in to practice high-level medicine." Luigi Ferrucci, Jan 14, 2021, Nature Aging

The core interest of the Bioinformatics is the investigation of intervention effects using gene expression (next-generation sequencing) data.
More generally, we also investigate biomarkers based on clinical, protein, microbiome and other data. Applications are in healthtech / aging research (including fibrosis, cellular senescence and inflammation), neurodegeneration and cancer. From our bioinformatics perspective, we (co-)coordinate two clinical and one preclinical trial, all done with some focus on biomarkers. See also the sections on "Funding" and Publications".

The Bioinformatics is composed of the following groups:

  • Medical Bioinformatics (Möller, Fuellen), focussed on intervention effects,
  • Junior Research Group Translational Bioinformatics (Barrantes).

The mission of the Biostatistics department can be found here.



With all the best wishes for a long healthspan
Georg Fuellen, Institute Director


Prof. Dr. Georg Fuellen
0381 494 7360
0381 494 7203


Ms Brauer
0381 494 7361
0381 494 7203


Institut für Biostatistik und Informatik in Medizin und Alternsforschung (IBIMA)
Ernst-Heydemann-Str. 8
18057 Rostock